Metric Snapshot
- Latest value
- -6842%
- Coverage range
- 31 Dec 2016 - 31 Dec 2018
- Fact rows
- 6
Shareable Research Card
URGN - UroGen Pharma Ltd. Operating Margin
This metric view shows URGN - UroGen Pharma Ltd. operating margin history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q4 2018
- Latest reported value
- -6842%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Financial Metric Page
UroGen Pharma Ltd.: Operating Margin
Latest period: Q4 2018. Period end: 31 Dec 2018. Units: %. Frequency: quarterly and annual.
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
What This Metric Tells You
- Shows the reported level of operating margin over 31 Dec 2016 - 31 Dec 2018.
- Use consecutive periods in the table to assess trend direction when YoY change is unavailable.
- Built from 6 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Operating Margin levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Global Warming Solutions, Inc. (["gwso"]) | 99905400% | Quarter - 30 Sep 2022 | Open Global Warming Solutions, Inc. Operating Margin |
| 2 | NAMI Corp. ([]) | 1080289% | Quarter - 31 Mar 2021 | Open NAMI Corp. Operating Margin |
| 3 | PharmaCyte Biotech, Inc. (["pmcb"]) | 396584% | Quarter - 31 Jan 2014 | Open PharmaCyte Biotech, Inc. Operating Margin |
| 4 | ALR Technologies SG Ltd. (["alrtf"]) | 180380% | Year - 31 Dec 2022 | Open ALR Technologies SG Ltd. Operating Margin |
| 5 | MUSTANG BIO, INC. (["mbio"]) | 83624% | Quarter - 30 Sep 2019 | Open MUSTANG BIO, INC. Operating Margin |
| 6 | DOMINION ENERGY SOUTH CAROLINA, INC. ([]) | 63100% | Quarter - 31 Dec 2020 | Open DOMINION ENERGY SOUTH CAROLINA, INC. Operating Margin |
Metric Details
- Metric
- Operating Margin (OperatingMargin)
- Taxonomy
- ratio
- Units tracked
- %
- Frequency coverage
- quarterly and annual
- History range
- 31 Dec 2016 - 31 Dec 2018
- Facts on this page
- 6
- Description
- The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Operating Margin, Quarterly (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)
UroGen Pharma Ltd. Quarterly Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2018 | -6842% | 01 Oct 2018 | 31 Dec 2018 | ||
| Q3 2018 | -4352% | 01 Jul 2018 | 30 Sep 2018 | ||
| Q2 2018 | -473% | 01 Apr 2018 | 30 Jun 2018 |
UroGen Pharma Ltd. Annual Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2018 | -6842% | -6598% | -2698% | 01 Jan 2018 | 31 Dec 2018 |
| 2017 | -245% | -249% | -5472% | 01 Jan 2017 | 31 Dec 2017 |
| 2016 | 4.6% | 01 Jan 2016 | 31 Dec 2016 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.